NK/NKT cells and aging

International Journal of Gerontology

Volumn 1, Issue 2, 2007, Pages 65-76

  Chen, Yu Jen ^a   Liao, Hui Fen ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Aging; Immune; NK cells; NKT cells

Indexed keywords

CD94 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A;

ADAPTIVE IMMUNITY; AGING; AUTOIMMUNE DISEASE; CANCER SUSCEPTIBILITY; CELL ACTIVITY; CELL AGING; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION CONTROL; INFECTION SENSITIVITY; INNATE IMMUNITY; LIFE SATISFACTION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 39549107103     PISSN: 18739598     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1873-9598(08)70025-5     Document Type: Review

References (113)

1. Srinivasan V, Maestroni G, Cardinali D, Esquifino A, Perumal SP, Miller S. Melatonin, immune function and aging. Immun Ageing 2005; 2: 17.
2. Mocchegiani E, Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell 2004; 3: 177-84.
3. Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis. Exp Gerontol 1990; 25: 499-522.
4. Tarazona R, Solana R, Ouyang Q, Pawelec G. Basic biology and clinical impact of immunosenescence. Exp Gerontol 2002; 37: 183-9.
5. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol 2004; 16: 151-6.
6. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999; 108: 1-7.
7. Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol 2003; 4: 1164-5.
8. Murasko DM, Jiang J. Response of aged mice to primary virus infections. Immunol Rev 2005; 205: 285-96.
9. Speziali E, Bethony J, Martins-Filho O, Fraga LA, Lemos DS, Souza LJ, et al. Production of interferon-gamma by natural killer cells and aging in chronic human schistosomiasis. Mediators Inflamm 2004; 13: 327-33.
10. Tsuboi H, Kawamura N, Hori R, Kobayashi F, Iwasaki Y, Takeuchi H, et al. Depressive symptoms and life satisfaction in elderly women are associated with natural killer cell number and cytotoxicity. Int J Behav Med 2005; 12: 236-43.
11. Mellick GD. CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key. J Neural Transm Suppl 2006; 70: 159-65.
12. Foltynie T, Matthews FE, Ishihara L, Brayne C; MRC CFAS. The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort. BMC Neurol 2006; 6: 29.
13. Yamaguchi M. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 2006; 126: 1117-37.
14. Kuriki K, Tajima K. The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pac J Cancer Prev 2006; 7: 495-501.
15. Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, et al. Altered lymphocyte distribution in Alzheimer's disease. J Psychiatr Res 2007; 41: 174-8.
16. Shalit F, Sredni B, Brodie C, Kott E, Huberman M. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin Immunol Immunopathol 1995; 75: 246-50.
17. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, et al. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease? J Psychiatr Res 2005; 39: 535-43.
18. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
19. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997; 155: 145-54.
20. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J, et al. Structure and function of major histocompatibility complex (MHC) class 1 specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38: 637-60.
21. Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, et al. NK phenotypic markers and IL2 response in NK cells from elderly people, Exp Gerontol 1999; 34: 253-65.
22. Miller RA. Aging and immune function. Int Rev Cytol 1991; 124: 187-215.
23. Levy SM, Fernstrom J, Herberman RB, Whiteside T, Lee J, Ward M, et al. Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: riskfactors for infectious disease. Life Sci 1991; 48: 107-16.
24. Malaguarnera L, Ferlito L, Imbesi RM, Gulizia GS, Di Mauro S, Maugeri D, et al. Immunosenescence: a review. Arch Gerontol Geriatr 2001; 32: 1-14.
25. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573-83.
26. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278: 1626-9.
27. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Vα4 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483-513.
28. Szalay G, Ladel CH, Blum C, Brossay L, Kronenberg M, Kaufmann SHE. Cutting edge: anti-CD1 monoclonal anti-body treatment reverses the production patterns of TGF-beta2 and Th1 cytokines and ameliorates listeriosis in mice. J Immunol 1999; 162: 6955-8.
29. Nakano Y, Hisaeda H, Sakai T, Zhang M, Maekawa Y, Zhang T, et al. Role of innate immune cells in protection against Toxoplasma gondii at inflamed sites. J Med Invest 2001; 48: 73-80.
30. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, et al. Monocyte chemoattractant protein-1 -dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 2001; 167: 6525-32.
31. Blackstock R, Murphy JW. Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells. Infect Immun 2004; 72: 5175-80.
32. + T cells, in mice. immunology 2004; 113: 371-7.
33. Browner WS, Kahn AJ, Ziv E, Reiner AP, Oshima J, Cawthon RM, et al. The genetics of human longevity. Am J Med 2004; 117: 851-60.
34. Mitchell BD, Hsueh WC, King TM, Pollin TI, Sorkin J, Agarwala R, et al. Heritability of life span in the old Order Amish. Am J Med Genet 2001; 102: 346-52.
35. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000; 408: 255-62.
36. Perls T, Kunkel LM, Puca AA. The genetics of exceptional human longevity. J Mol Neurosci 2002; 19: 233-8.
37. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 2005; 126: 351-61.
38. Bonafe M, Marchegiani F, Cardelli M, Olivieri F, Cavallone L, Giovagnetti S, et al. Genetic analysis of paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Fur J Hum Genet 2002; 10: 292-6.
39. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 2000; 121: 77-88.
40. + T cells are present within a population of intermediate TCR cells. J Immunol 1995; 155: 2972-83.
41. - extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic major histocompatibility complex antigens. Immunology 2001; 102: 450-9.
42. Sagiyama K, Tsuchida M, Kawamura H, Wang S, Li C, Bai X, et al. Age-related bias in function of natural killer T cells and granulocytes after stress: reciprocal association of steroid hormones and sympathetic nerves. Clin Exp Immunol 2004; 135: 56-63.
43. + subsets. Int Immunol 1998; 10: 1281-8.
44. Sfikakis PP, Gourgoulis GM, Moulopoulos LA, Kouvatseas G, Theofilopoulos AN, Dimopoulos MA. Age-related thymic activity in adults following chemotherapy-induced lymphopenia. Eur J Clin Invest 2005; 35: 380-7.
45. Castle SCC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31: 578-85.
46. Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001; 124: 392-7.
47. Potter JM, O'Donnell B, Carman WF, Roberts MA, Stott DJ. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Aging 19919; 28: 141-5.
48. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409: 1055-60.
49. Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A. Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol 2004; 39: 1447-58.
50. Schapiro JM, Segev Y, Rannon L, Alkan M, Rager-Zisman B. Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine. J Med Virol 1990; 30: 196-200.
51. De la Fuente M, Baeza I, Guayerbas N, Puerto M, Castillo C, Salazar V, et al. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology 2004; 5: 389-400.
52. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic context of natural killer receptor extended gene families. Immunol Rev 2001; 181: 20-38.
53. Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205: 158-69.
54. Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK. Reciprocal age related change in natural killer cell receptors for MHC class 1. Mech Ageing Dev 2005; 126: 722-31.
55. van Bergen J, Thompson A, van der Slik A, Ottenhoff THM, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004; 173: 6719-26.
56. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363-74.
57. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40-52.
58. Garcia CA, Robinson J, Guethlein LA, Parham P, Madrigal JA, Marsh SG. Human KIR sequences 2003. Immunogenetics 2003; 55: 227-39.
59. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429-34.
60. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002; 169: 2818-22.
61. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003; 52: 2639-42.
62. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001; 193: 1159-67.
63. Abedin S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR expression in aging T cells and in T cells of the aged: The new frontier into the exploration of protective immunity in the elderly. Exp Gerontol 2005; 40: 537-48.
64. MacDonald HR. CD1d-glycolipid tetramers: a new tool to monitor natural killer T cells in health and disease. J Exp Med 2000; 192: F15-9.
65. Damjanovich S, Gaspar R Jr, Bene L, Jenei A, Matyus L. Signal transduction in T lymphocytes and aging. Exp Gerontol 2003; 38: 231-6.
66. Douziech N, Seres I, Larbi A, Szikszay E, Roy PM, Arcand M, et al. Modulation of human lymphocyte proliferative response with aging. Exp Gerontol 2002; 37: 369-87.
67. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, et al. T cells and aging. Front Biosci 2002; 7: D1056-83.
68. + subsets. Mech Ageing Dev 2002; 123: 375-90.
69. Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, et al. Chemokine production by natural killer cells from nonagenarians. Eur J Immunol 2002; 32: 1524-9.
70. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol Res 1999; 20: 117-26.
71. Albright JW, Bream JH, Bere EW, Young HA, Winkler-Pickett R, Ortaldo JR. Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2. Exp Gerontol 2004; 39: 73-82.
72. Huppert FA, Pinto EM, Morgan K, Brayne C. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev 2003; 124: 449-51.
73. De la Fuente M. Effects of antioxidants on immune system ageing. Eur J Clin Nutr 2002; 56 (Suppl 3): S5-8.
74. Straub RH, Cutolo M, Zietz B, Scholmerich J. The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 2001; 122: 1591-611.
75. Puerto M, Guayerbas N, Alvarez P, De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neuroimmunol 2005; 165: 33-40.
76. Weinert BT, Timiras PS. invited review: theories of aging. J Appl Physiol 2003; 95: 1706-16.
77. DiPenta JM, Johnson JG, Murphy RJ. Natural killer cells and exercise training in the elderly: a review. Can J Appl Physiol 2004; 29: 419-43.
78. Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson RC, Butterworth DE, et al; Physical activity and immune function in elderly women. Med Sci Sports Exerc 1993; 25; 823-31.
79. Nieman DC. Exercise immunology: nutritional counter-measures. Can J Appl Physiol 2001; 26 (Suppl): S45-55.
80. Woods JA, Ceddia MA, Wolters BW, Evans JK, Lu Q, McAuley E. Effects of 6 months of moderate aerobic exercise training on immune function in the elderly. Mech Ageing Dev 1999; 109: 1-19.
81. Gibney MJ, Gibney ER. Diet, genes and disease: implications for nutrition policy. Proc Nutr Soc 2004; 63: 491-500.
82. Failla ML. Trace elements and host defense: recent advances and continuing challenges. J Nutr 2003; 133 (5 Suppl 1): 1443S-7S.
83. Arlt W, Hewison M. Hormones and immune function: implications of aging. Aging Cell 2004; 3: 209-16.
84. Nelson RJ. Seasonal immune function and sickness responses. Trends Immunol 2004; 25: 187-92.
85. Maestroni GJ, Conti A, Pierpaoli W. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 1986; 13: 19-30.
86. Cardinali DP, Pevet P. Basic aspects of melatonin action. Sleep Med Rev 1998; 2: 175-90.
87. Angeli A, Gatti G, Sartori ML, Maisera RG. Chronobiological aspects of the neuroendocrine-immune network. Regulation of human natural killer (NK) cell activity as a model. Chronobiologia 1992; 191: 93-110.
88. Currier NL, Sun LZ, Miller SC. Exogenous melatonin: quantitative enhancement in vivo of cells mediating nonspecific immunity. J Neuroimmunol 2000; 104: 101-8.
89. Garcia-Maurino S, Pozo D, Calvo JR, Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 2000; 29: 129-37.
90. Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000; 130 (5 Suppl): 1399S-406S.
91. Mills CF. Biochemical and physiological indicators of mineral status in animals: copper, cobalt and zinc. J Anim Sci 1987; 65: 1702-11.
92. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993; 73: 79-118.
93. Berg JM, Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996; 271: 1081-5.
94. Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 2000; 173: 17-26.
95. Fraker PJ, Telford WG. A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 1997; 215: 229-36.
96. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-4.
97. Cai L, Satoh M, Tohyama C, Cherian MG. Metallothionein in radiation exposure: its induction and protective role. Toxicology 1999; 132: 85-98.
98. Ashok BT, Ali R. The aging paradox: free radical theory of aging. Exp Gerontol 1999; 34: 293-303.
99. Mocchegiani E, Giacconi R, Cipriano C, Muzzioli M, Gasparini N, Moresi R, et al. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 2002; 37: 349-57.
100. Mocchegiani E, Muzzioli M, Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 2000; 1: 133-43.
101. Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997; 18: 519-21.
102. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol 2006; 80: 1-9.
103. Mocchegiani E, Muzzioli M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 2000; 130 (5 Suppl): S1424-31.
104. Moroni F, Di Paolo ML, Rigo A, Cipriano C, Giacconi R, Recchioni R, et al. interrelationship among neutrophil efficiency, inflammation, antioxiclant activity and zinc pool in very old age. Biogerontology 2005; 6: 271-81.
105. Rink L, Kirchner H. Zinc-altered immune function and cytokine production. J Nutr 2000; 130 (5 Suppl): 1407S-11S.
106. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000; 182 (Suppl 1): S62-8.
107. Aung NN, Yoshinaga J, Takahashi JI. Dietary intake of toxic and essential trace elements by the children and parents living in Tokyo Metropolitan Area, Japan. Food Addit Contam 2006; 3: 883-94.
108. Ghoneum M. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochem Biophys Res Commun 1998; 243: 25-9.
109. Ghoneum M, Jewett A. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev 2000; 24: 314-24.
110. Ghoneum M, Gollapudi S. Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Lett 2003; 201: 41-9.
111. Markus J, Miller A, Smith M, Orengo I. Metastatic hemangiopericytoma of the skin treated with wide local excision and MGN-3. Dermatol Surg 2006; 32: 145-7.
112. Ghoneum M, Abedi S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol 2004; 56: 1581-8.
113. Helfand SL, Rogina B. Molecular genetics of aging in the fly: is this the end of the beginning? Bioessays 2003; 25: 134-41.